Absci Investor Presentation Deck

CASE STUDY: CONJUGATING TO NON-STANDARD AMINO ACIDS Easy conjugation producing homogenous drug substances Intensity 1.0E+04 8.0e+03- 6.0E+03. 4.0E+03 2.0E+03. 0.0e +00 Conjugated Bionic™ trastuzumab Bionic™ trastuzumab 135k ABSCI CORPORATION 2023 ALL RIGHTS RESERVED 140k 145k Mass (Da) Successful conjugation of payload 150k 155k absci. 39

View entire presentation